Jahrgang 2015
Greene SJ, Maggioni AP, Fonarow GC, Solomon SD, Böhm M, Kandra A, Prescott MF, Reimund B, Hua TA, Lesogor A, Zannad F, Gheorghiade M for the ASTRONAUT Investigators and Coordinators (2015)
Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
Eur J Heart Fail 17: 98-108Linz D, Böhm M (2015)
Renal denervation for treatment of hypertension and beyond.
Clin Res Cardiol 104: 87-88Fengler K, Fuernau G, Desch S, Eitel I, Neumann FJ, Olbrich HG, de Waha A, de Waha S, Richardt G, Hennersdorf M, Empen K, Hambrecht R, Fuhrmann J, Böhm M, Poess J, Strasser R, Schneider S, Schuler G, Werdan K, Zeymer U, Thiele H (2015)
Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.
Clin Res Cardiol 104: 71-78Schmieder RE, Schutte R, Schumacher H, Böhm M, Mancia G, Weber MA, McQueen M, Teo K, Yusuf S on behalf of the ONTARGET/TRANSCEND investigators (2015)
Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies
Diabetologia 57: 2019-2029Ewen S, Ukena C, Linz D, Kindermann I, Cremers B, Laufs U, Wagenpfeil S, Schmieder RE, Böhm M, Mahfoud F (2015)
Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension.
Hypertension 65: 193-199Böhm M, Papoutsis K, Gottwik M, Ukena C (2015)
Publication performance of women compared to men in german cardiology.
Int J Cardiol 181C: 267-269Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G, on behalf of the GSR Investigators (2015)
First report of the global symplicity registry on the effect of renal artery denervation in patients with uncontrolled hypertension.
Hypertension 65: 766-774Borer JS, Böhm M, Ford I, Komajda M, Swedberg K, Tavazzi L (2015)
Effect of ivabradine on early readmissions after hospitalization for worsening of heart failure.
JACC Heart Failure 3 (letter): 268-269Pöss J, Ewen S, Schmieder RE, Muhler S, Vonend O, Ott C, Linz D, Geisel J, Rump LC, Schlaich M, Böhm M, Mahfoud F (2015)
Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.
Clin Res Cardiol 104: 672-678Böhm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R, Custodis F, Diener HC, Laufs U, Lonn E, Sliwa K, Teo K, Fagard R, Redon J, Sleight P, Anderson C, O’Donnell M, Yusuf S (2015)
Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.
Hypertension 65: 651-661Weingärtner O, Husche C, Schött HF, Speer T, Böhm M, Miller CM, McCarthy F, Plat J, L[tjohann D, Laufs U (2015)
Vascular effects of oxysterols and oxyphytosterols in apoE-/- mice.
Atherosclerosis 240: 73-79Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, schmieder RE (2015)
Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
J Hypertens 33: 1261-1266Papoutsis K, Ukena C, Gottwik M, Böhm M (2015)
Prädiktiver Wert der Evaluation von Kongressabstracts für die Publikationshäufigkeit und -qualität: Analyse der Jahreskongresse der Deutschen Gesellschaft für Kardiologie.
Dtsch Med Wochenschr 140: e56-e59Linz D, van Hunnik A, Hohl M, Mahfoud F, Wolf M, Neuberger HR, Casadei B, Reilly SN, Verheule S, Böhm M, schotten U (2015)
Catheter-based renal denervation reduces atrial nerve sprouting and complexity of atrial fibrillation in goats.
Circ Arrhythm Electrophysiol 8: 466-474Kleber FX, Schulz A, Waliszewski M, Hauschild T, Böhm M, Dietz U, Cremers B, Scheller B, Clever YP (2015)
Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
Clin Res Cardiol 104: 217-225Pitt B, Anker SD, Böhm M, Gheorghiade M, Køber L, Krum H, Maggioni AP, Ponikowski P, Voors AA, Zannad F, Nowack C, So-Young K, Pieper A, Kimmeskamp-Kirschbaum N, Filippatos G (2015)
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.
Eur J Heart Fail 17: 224-232Böhm M, S. Borer JS, Camm J, Ford I, Lloyd SM, Komajda M, Tavazzi L, Talajic M, Lainscak M, Reil JC, Ukena C, Swedberg K (2015)
Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.
Eur J Heart Fail 17: 518-526Pöss J, Ukena C, Kindermann I, Ehrlich P, Fuernau G, Ewen S, Mahfoud F, Kriechbaum S, Böhm M, Link A (2015)
Angiopoietin-2 and outcome in patients with acute decompensated heart failure.
Clin Res Cardiol 104: 380-387Linz D, Hohl M, Ukena C, Mahfoud F, Wirth K, Neuberger HR, Böhm M (2015)
Obstructive respiratory events and premature atrial contractions after cardioversion.
Eur Respir J 45: 1332-1340Bocchi EA, Böhm M, Borer JS, Ford I, Komajda M, Swedberg K, Tavazzi L, on behalf of SHIFT investigators (2015)
Effect of combining ivabradine and β-blockers: Focus on the use of carvedilol in the SHIFT population.
Cardiology 131: 218-224Schirmer SH, Sayed MMYA, Reil JC, Lavall D, Ukena C, Linz D, Mahfoud F, Böhm M (2015)
Atrial remodeling following catheter-based renal denervation occurs in a blood pressure–and heart rate–independent manner.
J Am Coll Cardiol Intv 8: 972-980Böhm M, Ezekowitz MD, Connolly SJ, Eikelboom JW, Hohnloser SH, Reilly PA, Schumacher H, Brueckmann M, Schirmer SH, Kratz MT, Yusuf S, Diener HC, Hijazi Z, Wallentin L (2015)
Changes in renal function in patients with atrial fibrillation.
J Am Coll Cardiol 65: 2481-2493Böhm M, Schumacher H, Schmieder RE, MannJFE, Teo K, Lonn E, Sleight P, Mancia G, Linz D, Mahfoud F, Ukena C, Sliwa K, Bakris G, Yusuf S (2015)
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.
J Intern Med 278: 38-49Heer T, Hochadel M, Schmidt K, Mehilli J, Zahn R, Kuck KH, Hamm C, Böhm M, Ertl G, Andresen D, Massberg S, Senges J, Pilz G, Gitt AK, Zeymer U (2015)
Gender differences in therapeutic recommendation after diagnostic coronary angiography: insights from the Coronary Angiography and PCI Registry of the German Society of Cardiology.
Clin Res Cardiol 104: 507-517Greulich S, Kindermann I, Schumm J, Perne A, Birkmaier S, Grün S, Ong P, Schäufele T, Klingel K, Schneider S, Kandolf R, Böhm M, Sechtem U, Marholdt H (2015)
Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy.
Clin Res Cardiol: [doi: 10.1007/s00392-015-0884-6]Puhl SL, Müller A, Wagner M, Devaux Y, Böhm M, Wagner DR, Maack C (2015)
Exercise attenuates inflammation and limits scar thinning after myocardial infarction in mice.
Am J Physiol Heart Circ Physiol 309: H345-H359Libhaber E, Sliwa K, Bachelier K, Lamont K, Böhm M (2015)
Low systolic blood pressure and high resting heart rate as predictors of outcome in patients with peripartum cardiomyopathy.
Int J Cardiol 190: 376-382Lenski M, Schleider G, Kohlhaas M, Adrian L, Adam O, Tian Q, Kaestner L, Lipp P, Lehrke M, Maack C, Böhm M, Laufs U (2015)
Arrhythmia causes lipid accumulation and reduced glucose uptake.
Basic Res Cardiol 110: 40Ford I, Robertson M, Komajda M, Böhm M, Borer, JS, Tavazzi L, Swedberg K on behalf of the SHIFT investigators (2015)
Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure.
Int J Cardiol 184: 163-169Kim BK, Böhm M, Mahfoud F, Mancia G, Park S, Hong Mk, Kim HS, Park SJ, Park CG, Seung KB, Gwon HC, Choi DJ, Ahn TH, Kim CJ, Kwon HM, Esler M, Jang YS (2015)
Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea)
J Human Hypertens: [doi: 10.1038/jhh.2015.77]Nickel AG, von Hardenberg A, Hohl M, Löffler JR, Kohlhaas M, Becker J, Reil JC, Kazakov A, Bonnekoh J, Stadelmaier M, Puhl SL, Wagner M, Bogeski I, Cortassa S, Kappl R, Pasieka B, Lafontaine M, Lancaster CRD, Blacker TS, Hall AR, Duchen MR, Kästner L, Lipp P, Zeller T, Müller C, Knopp A, Laufs U, Böhm M, Hoth M, Maack C (2015)
Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure.
Cell Metabolism 22: 472-484Schirmer SH, Millenaar DN, Werner C, Schuh L, Degen A, Bettink SI, Lipp P, van Rooijen N, Meyer T, Böhm M, Laufs U (2015)
Exercise promotes collateral artery growth mediated by monocytic nitric oxide.
Arterioscler Thromb Vasc Biol 35: 1862-1871Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, Seifert B, Hellermann J, Schwyzer M, Eisenhardt K, Jenewein J, Franke J, Katus HA, Burgdorf C, Schunkert H, Moeller C, Thiele H, Bauersachs J, Tschöpe C, Schultheiss HP, Laney CA, Rajan L, Michels G, Pfister R, Ukena C, Böhm M, Erbel R, Cuneo A, Kuck KH, Jacobshagen C, Hasenfuss G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Cuculi F, Banning A, Fischer TA, Vasankari A, Airaksinen KEJ, Fijalkowski M, Rynkiewicz A, Pawlak M, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Franz WM, Empen K, Felix SB, Delmas C, Lairez O, Erne P, Bax JJ, Ford I, Ruschitzka F, Prasad A, Lüscher TF (2015)
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy.
N Engl J Med 373: 929-938Adam O, Zimmer C, Hanke N, Hartmann RW, Klemmer B, Böhm M, Laufs U (2015)
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
J Mol Cell Cardiol 85: 140-150Böhm M, Tschöpe C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Lins K, Strunz AM, Tebbe U (2015)
Treatment of heart failure in real-world clinical practice: findings from the REFLECT-HF Registry in patients with NYHA class ii symptoms and a reduced ejection fraction.
Clin Cardiol 38: 200-207Böhm M, Schumacher H, Linz D, Reil JC, Ukena C, Lonn E, Teo K, Sliwa K, Schmieder RE, Sleight P, Yusuf S (2015)
Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies.
J Intern Med 278: 303-312Komajda M, Tavazzi L, Francq BG, Böhm M, Borer JS, Ford I, Swedberg K on behalf oft he SHIFT investigators (2015)
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
Eur J Heart Fail 17: 1294-1301Ewen S, Cremers B, Meyer MR, Donazzan L, Kindermann I, Ukena C, Helfer AG, Maurer HH, Laufs U, Grassi G, Böhm M, Mahfoud F (2015)
Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance.
J Hypertens 33: 2519-2525Ewen S, Dörr O, Ukena C, Linz D, Cremers B, Laufs U, Hamm C, Nef H, Bauer A, Mancia G, Böhm M, Mahfoud F (2015)
Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
J Hypertens 33:2512-2518Haghikia A, Podewski E, Berliner D, Sonnenschein K, Fischer D, Angermann CE, Böhm M, Röntgen P, Bauersachs J, Hilfiker-Kleiner D (2015)
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Clin Res Cardiol 104: 911-917Hamill V, Ford I, Fox K, Böhm M, Borer JS, Ferrari R, Komajda M, Steg PG, Tavazzi L, Tendera M, Swedberg K (2015)
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction.
Am J Med 128: 1102-1108Böhm M, Robertson M, Ford I, Borer JS, Komajda M, Kindermann I, Maack C, Lainscak M, Swedberg K, Tavazzi L (2015)
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)
Am J Cardiol 116: 1890-1897Kazakov A, Meier T, Werner C, Hall R, Klemmer B, Körbel C, Lammert F, Maack C, Böhm M, Laufs U (2015)
C-kit+ resident cardiac stem cells improve left ventricular fibrosis in pressure overload.
Stem Cell Res 15: 700-711Dörr O, Ewen S, Liebetrau C, Möllmann H, Gaede L, Linz D, Hohl M, Troidl C, Bauer T, Böhm M, Hamm C, Mahfoud F, Nef H (2015)
Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation.
Clin Res Cardiol 104: 1064-1071Ewen S, Meyer MR, Cremers B, Laufs U, Helfer AG, Linz D, Kindermann I, Ukena C, Burnier M, Wagenpfeil S, Maurer HH, Böhm M, Mahfoud F (2015)
Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
Clin Res Cardiol 104: 1097-1105Pöss J, Furenau G, Denks D, Desch S, Eitel I, de Waha S, Link A, Schuler G, Adams V, Böhm M, Thiele H (2015)
Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock — a biomarker substudy of the IABP-SHOCK II-Trial.
Eur J Heart Fail 17: 1152-1160Böhm M, Ezekowitz MD, Connolly SJ, Eikelboom JW, Hohnloser SH, Reilly PA, Schumacher H, Brueckmann M, Schirmer SH, Kratz MT, Yusuf S, Diener HC, Hijazi Z, Wallentin L (2015)
Reply: Anticoagulant-Related Nephropathy.
J Am Coll Cardiol 66: 2682Ewen S, Baumgarten T, Rettig-Ewen V, Mahfoud F, Griese-Mammen N, Schulz M, Böhm M, Laufs U (2015)
Analyses of drugs stored at home by elderly patients with chronic heart failure.
Clin Res Cardiol 104: 320-327Greene SJ, Fonarow GC, Solomon SD, Subacius H, Maggioni AP, Böhm M, Lewis EF, Zannad F, Gheorghiade M, ASTRONAUT Investigators and Coordinators (2015)
Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial.
Eur. J. Heart Fail. 17: 591-600Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H, Schneider S, Ebelt H, Werdan K, Zeymer U, I ABP-SHOCK II Trial Investigators (2015)
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Am Heart J 169: e7-e8Mahfoud F, Tunev S, Ewen S, Cremers B, Ruwart J, Schulz-Jander D, Linz D, Davies J, Kandzari DE, Whitbourn R, Böhm M, Melder RJ. (2015)
Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation.
J Am Coll Cardiol 66: 1766-1775Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC, PARADIGM-HF Investigators and Coordinators. (2015)
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Circulation 131: 54-61Pöss J, Kriechbaum S, Ewen S, Graf J, Häger I, Hennersdorf M, Petros S, Link A, Böhm M, Thiele H, Laufs U (2015)
First-in-man analysis of the i-cor assist device in patients with cardiogenic shock.
Eur Heart J Acute Cardiovasc Care 4: 475-481McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Bĕlohlávek J, Böhm M, Boytsov S, Burgess L, Cabrera W, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R, PARADIGM-HF Committees and Investigators(2015)
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure.
Eur. Heart J. 36: 434-439
